Literature DB >> 26598921

Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports.

Takeshi Zoshima1, Kazunori Yamada, Satoshi Hara, Ichiro Mizushima, Masakazu Yamagishi, Kenichi Harada, Yasuharu Sato, Mitsuhiro Kawano.   

Abstract

Multicentric Castleman disease is a benign lymphoproliferative disorder with heterogenous clinical symptoms and involves systemic organs in addition to lymph nodes. Elevated serum IgG4 levels and IgG4-positive plasma cell (IgG4+PC) infiltrates have been reported in lymph nodes, lung and skin in some multicentric Castleman disease cases, resembling IgG4-related disease (IgG4-RD) histologically. However, no report has been available regarding IgG4+PC infiltration in the kidneys of multicentric Castleman disease. Here, we report 2 cases of multicentric Castleman disease complicated by IgG4-related disease (IgG4-RD) histologically. However, there has been no report published on PC-rich tubulointerstitial nephritis, lymphadenopathy, with numerous IgG4+PC infiltration, and elevated serum IgG4 levels, mimicking IgG4-RD. The blood examinations revealed systemic inflammation and elevated C-reactive protein and interleukin-6 levels. Corticosteroid therapy was partially effective in both cases, and combination therapy of corticosteroid and tocilizumab was needed in both cases. Moreover, after triple therapy with corticosteroid, rituximab and cyclophosphamide were used in 1 case to tame the severe inflammation. The present cases suggest that if continuously elevated serum C-reactive protein levels and partial corticosteroid responsiveness are encountered, multicentric Castleman disease should be considered rather than IgG4-RD as a differential diagnosis even if serum IgG4 is elevated and IgG4+PCs infiltrate systemic organs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26598921     DOI: 10.1097/PAS.0000000000000575

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease.

Authors:  Akihiro Manabe; Takuro Igawa; Mai Takeuchi; Yuka Gion; Tadashi Yoshino; Yasuharu Sato
Journal:  Med Mol Morphol       Date:  2016-07-20       Impact factor: 2.309

2.  Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.

Authors:  Asami Nishikori; Midori Filiz Nishimura; Yoshito Nishimura; Kenji Notohara; Akira Satou; Masafumi Moriyama; Seiji Nakamura; Yasuharu Sato
Journal:  Pathol Int       Date:  2021-11-11       Impact factor: 2.121

Review 3.  Immunoglobulin G4-related kidney diseases: An updated review.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  World J Nephrol       Date:  2018-01-06

4.  Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.

Authors:  Takanori Sasaki; Mitsuhiro Akiyama; Yuko Kaneko; Takehiko Mori; Hidekata Yasuoka; Katsuya Suzuki; Kunihiro Yamaoka; Shinichiro Okamoto; Tsutomu Takeuchi
Journal:  RMD Open       Date:  2017-07-18

Review 5.  Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: A case report and literature review.

Authors:  Ryusuke Anan; Mitsuhiro Akiyama; Yuko Kaneko; Jun Kikuchi; Kazuko Suzuki; Shiro Matsubara; Tsutomu Takeuchi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease.

Authors:  Kyoko Otani; Dai Inoue; Kohei Fujikura; Takahiro Komori; Shiho Abe-Suzuki; Takuma Tajiri; Tomoo Itoh; Yoh Zen
Journal:  Oncotarget       Date:  2018-01-09

7.  Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease.

Authors:  Yanyan Han; Takuro Igawa; Kyohei Ogino; Asami Nishikori; Yuka Gion; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2020-03-08

8.  Clinical implications of elevated serum interleukin-6 in IgG4-related disease.

Authors:  Satoshi Tsukuda; Tsukasa Ikeura; Takashi Ito; Koh Nakamaru; Masataka Masuda; Yuichi Hori; Manami Ikemune; Masato Yanagawa; Toshihiro Tanaka; Takashi Tomiyama; Takashi Yamaguchi; Yugo Ando; Kazushige Uchida; Toshiro Fukui; Akiyoshi Nishio; Rika Terasawa; Noboru Tanigawa; Kazuichi Okazaki
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

9.  Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.

Authors:  Kosuke Minaga; Tomohiro Watanabe; Akane Hara; Ken Kamata; Shunsuke Omoto; Atsushi Nakai; Yasuo Otsuka; Ikue Sekai; Tomoe Yoshikawa; Kentaro Yamao; Mamoru Takenaka; Yasutaka Chiba; Masatoshi Kudo
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

10.  IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.

Authors:  Yasuhiro Kinugawa; Takeshi Uehara; Mai Iwaya; Shiho Asaka; Shota Kobayashi; Tomoyuki Nakajima; Masamichi Komatsu; Masanori Yasuo; Hiroshi Yamamoto; Hiroyoshi Ota
Journal:  BMC Pulm Med       Date:  2021-07-10       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.